Some Physicians Switch Patients Off Invokana after FDA Warning
Doubled risk of amputations appears to be affecting usage by Cheryl Clark, Senior Staff Writer inewsource/MedPage Today September 02, 2017 Some physicians and their hospital-affiliated medical groups are scurrying to take patients off of the diabetes drug canagliflozin (Invokana), after results [...]